PMA (Phorbol 12-myristate 13-acetate)

製品コードS7791 バッチS779102

印刷

化学情報

Synonyms

12-O-Tetradecanoylphorbol-13-acetate,TPA, Phorbol myristate acetate

Storage
(From the date of receipt)

3 years -20°C(in the dark) powder

化学式

C₃₆H₅₆O₈

分子量

616.83

CAS No.

16561-29-8

Solubility (25°C)*

体外

DMSO

100 mg/mL (162.11 mM)

Ethanol

100 mg/mL (162.11 mM)

Water

Insoluble

体内（毎回新しく調製した物を用意してください）

Homogeneous suspension

CMC-NA

≥5mg/ml

Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.

* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液（一定の濃度）を調合する

生物活性

製品説明	PMA (Phorbol 12-myristate 13-acetate), a potent activator of PKC, is active at nanomolar concentrations. Phorbol 12-myristate 13-acetate (PMA) induces sphingosine-1-phosphate (S1P).
in vitro	In endothelial cells, PMA (Phorbol 12-myristate 13-acetate) increases levels of Thy-1 mRNA and protein, induces Thy-1 up-regulation and inhibits capillary-like tube formation and endothelial cell migration.^[1]
in vivo	In the zebrafish model, PMA (Phorbol 12-myristate 13-acetate) initially enhances endothelial cell migration, subsequently activating the PKC-δ/Syk/NF-κB-mediated pathway to up-regulate Thy-1, which in turn inhibits endothelial cell migration.^[1]

プロトコル(参考用のみ)

細胞アッセイ	細胞株	Human umbilical vein endothelial cells (HUVECs), human dermal microvascular endothelial cells (HDMECs), human pulmonary microvascular endothelial cell line (HPMECs)
	濃度	20 ng/mL
	反応時間	14, 16 and 18 h for levels of Ty-1 mRNA, 20, 24 and 28 h for levels of Ty-1 protein
	実験の流れ	After transfection with Ty-1 promoter plasmid (0.5 μg) and Renilla plasmid (50ng), the cells are treated with PMA (Phorbol 12-myristate 13-acetate) at 20ng/mL, washed with ice-cold phosphate-buffered saline (PBS), and then lysed in passive lysis buffer. Luciferase activity is measured using the Dual-Luciferase Reporter Assay kit.
動物実験	動物モデル	Transgenic Tg(fi1:EGFP)y1 embryos of zebrafsh (Danio rerio)
	投薬量	20 ng/mL
	投与方法	--

参考

https://pubmed.ncbi.nlm.nih.gov/30389973/

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

Neutrophil extracellular traps license macrophage production of chemokines to facilitate CD8+ T cell infiltration in obstruction-induced renal fibrosis [ Protein Cell, 2025, pwaf020]	PubMed: 39998389
Granzyme B activated near-infrared-II ratiometric fluorescent nanoprobe for early detection of tumor response to immunotherapy [ Nat Commun, 2025, 16(1):8054]	PubMed: 40877261
Simvastatin overcomes the pPCK1-pLDHA-SPRINGlac axis-mediated ferroptosis and chemo-immunotherapy resistance in AKT-hyperactivated intrahepatic cholangiocarcinoma [ Cancer Commun (Lond), 2025, 10.1002/cac2.70036]	PubMed: 40443016
Unveiling the mechanisms of CEBPD-orchestrated TAM polarization through RGS2/PAR2 pathway and its impact on ICB efficacy in clear cell renal cell carcinoma [ J Immunother Cancer, 2025, 13(7)e010898]	PubMed: 40659446
Dynamic phosphorylation of Fascin-1 orchestrates microglial phagocytosis and neurological recovery after spinal cord injury [ J Neuroinflammation, 2025, 22(1):121]	PubMed: 40281563
The Hippo pathway kinase MST1 mediates a feedback loop to maintain NLRP3 inflammasome homeostasis [ Cell Rep, 2025, 44(8):116076]	PubMed: 40716062
Rottlerin inhibits PKCδ to attenuate pulmonary fibrosis by suppressing NLRC4/ASC-mediated pyroptosis [ Phytomedicine, 2025, 146:157154]	PubMed: 40819638
FTO-mediated the destabilization of RASGRF1 mRNA impedes thyroid cancer progression and suppresses macrophage M2 polarization [ Cell Biol Toxicol, 2025, 41(1):123]	PubMed: 40760370
Targeting CCR5 with miltefosine as a therapeutic strategy for thrombocytopenia [ iScience, 2025, 28(5):112379]	PubMed: 40292315
Ursolic acid ameliorates cerebral ischemia-reperfusion injury by inhibiting NF-κB/NLRP3-mediated microglia pyroptosis and neuroinflammation [ Front Pharmacol, 2025, 16:1622131]	PubMed: 40717974

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。